[go: up one dir, main page]

NO801018L - Diagnostisk fremgangsmaate. - Google Patents

Diagnostisk fremgangsmaate.

Info

Publication number
NO801018L
NO801018L NO801018A NO801018A NO801018L NO 801018 L NO801018 L NO 801018L NO 801018 A NO801018 A NO 801018A NO 801018 A NO801018 A NO 801018A NO 801018 L NO801018 L NO 801018L
Authority
NO
Norway
Prior art keywords
cancer
concentration
dna
protein
bleomycin
Prior art date
Application number
NO801018A
Other languages
English (en)
Norwegian (no)
Inventor
Stanley T Crooke
Louis Galvan
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NO801018L publication Critical patent/NO801018L/no

Links

Classifications

    • G01N33/5755
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G01N33/57585
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875Nucleoproteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4703Regulators; Modulating activity
    • G01N2333/4704Inhibitors; Supressors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475Assays involving growth factors
    • G01N2333/50Fibroblast growth factors [FGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Sink And Installation For Waste Water (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
NO801018A 1979-04-10 1980-04-09 Diagnostisk fremgangsmaate. NO801018L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2873279A 1979-04-10 1979-04-10

Publications (1)

Publication Number Publication Date
NO801018L true NO801018L (no) 1980-10-13

Family

ID=21845111

Family Applications (1)

Application Number Title Priority Date Filing Date
NO801018A NO801018L (no) 1979-04-10 1980-04-09 Diagnostisk fremgangsmaate.

Country Status (24)

Country Link
JP (1) JPS55143441A (es)
KR (1) KR830002502A (es)
AR (1) AR222700A1 (es)
AT (1) AT365343B (es)
AU (1) AU536522B2 (es)
BE (1) BE882669A (es)
CH (1) CH644453A5 (es)
DE (1) DE3013837A1 (es)
DK (1) DK149980A (es)
ES (1) ES8103380A1 (es)
FI (1) FI801078A7 (es)
FR (1) FR2454099A1 (es)
GB (1) GB2047712B (es)
GR (1) GR67692B (es)
HU (1) HU183122B (es)
IE (1) IE49981B1 (es)
IL (1) IL59772A (es)
IT (1) IT1143135B (es)
LU (1) LU82345A1 (es)
NL (1) NL8002094A (es)
NO (1) NO801018L (es)
PH (1) PH15637A (es)
SE (1) SE8002602L (es)
ZA (1) ZA802141B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3524644A1 (de) * 1985-07-10 1987-01-15 Heyl Chem Pharm Undulin und dessen peptidfragmente, verfahren zu deren herstellung und ihre verwendung

Also Published As

Publication number Publication date
FI801078A7 (fi) 1981-01-01
IE800693L (en) 1980-10-10
GB2047712B (en) 1983-02-23
HU183122B (en) 1984-04-28
IL59772A0 (en) 1980-06-30
FR2454099A1 (fr) 1980-11-07
NL8002094A (nl) 1980-10-14
KR830002502A (ko) 1983-05-30
IL59772A (en) 1983-05-15
SE8002602L (sv) 1980-12-09
DK149980A (da) 1980-10-11
GR67692B (es) 1981-09-07
PH15637A (en) 1983-03-11
ATA195780A (de) 1981-05-15
AR222700A1 (es) 1981-06-15
IT1143135B (it) 1986-10-22
DE3013837A1 (de) 1980-10-30
IE49981B1 (en) 1986-01-22
AT365343B (de) 1982-01-11
CH644453A5 (fr) 1984-07-31
AU5719380A (en) 1980-10-16
GB2047712A (en) 1980-12-03
AU536522B2 (en) 1984-05-10
BE882669A (fr) 1980-10-06
ZA802141B (en) 1981-04-29
IT8048370A0 (it) 1980-04-09
FR2454099B1 (es) 1984-01-27
ES490396A0 (es) 1981-02-16
ES8103380A1 (es) 1981-02-16
LU82345A1 (fr) 1980-12-16
JPS55143441A (en) 1980-11-08

Similar Documents

Publication Publication Date Title
Varnum et al. Proteomic characterization of nipple aspirate fluid: identification of potential biomarkers of breast cancer
Metzgar et al. Detection of a pancreatic cancer-associated antigen (DU-PAN-2 antigen) in serum and ascites of patients with adenocarcinoma.
US7763435B2 (en) Method for diagnosis of alzheimer's disease with determination of LASP-1 immunoreactivity
US4270924A (en) Diagnostic method for detecting cancer
US4188189A (en) Quantitative testing for vitamin B12
Hansen et al. Electrophoretic analysis of the glycan microheterogeneity of orosomucoid in cancer and inflammation
DE60107022T2 (de) Verfahren zur Detektion von Prostata-spezifischem Membran-Antigen in Serum
US4351822A (en) Quantitative testing for vitamin B12
Kreutzer et al. An immunological turbidimetric method for serum transferrin determination
US6759204B2 (en) Method and kit for early diagnosis of cancer
Moncure et al. Immunological and histochemical evaluation of marrow aspirates in patients with prostatic carcinoma
NO801018L (no) Diagnostisk fremgangsmaate.
US5955287A (en) Method of determining level of biological substances elevated in the presence of cancer and other neoplasms
JPH0580053A (ja) ヒト子宮体癌細胞の免疫化学的検出方法
WO2021045180A1 (ja) 胃がんマーカー、及びこれを用いた検査方法
RU2147124C1 (ru) Способ оценки состояния гомеостаза
Buffone et al. Characterization and evaluation of immunochemical methods for the measurement of fecal α 1-antitrypsin
FI60567C (fi) Preparat foer anvaendning vid diagnostisering av kancer och foerfarande foer dess framstaellning
US4493898A (en) Method for detecting and monitoring cancer
Knapp Partial Characterisation of an Oncofetal Pancreatic Antigen: Its Role in the Differential Diagnosis and Therapy of Patients with Pancreatic Cancer
Mirowski et al. Serological and immunohistochemical detection of a 65-kDa oncofetal protein in breast cancer
RU2039985C1 (ru) Способ диагностики злокачественного заболевания и его рецидива
Gohji et al. Serum basic fetoprotein in patients with renal cell carcinoma
Mustala et al. A New Modification for the Determination of 5-Ydroxy-Indole-Acetic Acid (5HIAA) in Urine Unspecific Nitrosonaphthol Reactions and Their Elimination
KR101403019B1 (ko) 폐암 진단용 마커